Cytovance Biologics announces Plasmid DNA Manufacturing: An Optimized Platform Process Webinar OKLAHOMA CITY, June 14, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial and gene therapy...

Cytovance Biologics Announces Yuk Chun Chiu as Vice President of Manufacturing Operations OKLAHOMA CITY, July 06, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces Yuk Chun Chiu as Vice...

Cytovance Biologics and Akshaya Bio Announce Collaboration Agreement of Therapeutics for Treatment of Coronavirus and Hepatitis B Virus Infections OKLAHOMA CITY, April 23, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a USA-based contract development and manufacturing organization (CDMO) and a subsidiary of the Shenzhen Hepalink...